Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

This discovery may lead to a novel treatment approach that targets underlying brain pressure mechanisms rather than just managing symptoms. The research suggests that liraglutide, a drug originally ...

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

Migraines are one of the world's most common ... GLP-1 diabetes drugs like Ozempic found effective against migraines. Joseph ... none found these problematic enough to discontinue treatment.